Literature DB >> 17912501

Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers.

Mitul A Mehta1, Andrew J Montgomery, Yuri Kitamura, Paul M Grasby.   

Abstract

RATIONALE: In humans, the effects of dopaminergic agents administered systemically are less clear-cut than studies in experimental animals where agents can be applied locally in the brain. DA receptor occupancy could clearly contribute to the variance in findings, although this is typically not known.
OBJECTIVES: The objective of the study was to measure the DA D2 receptor occupancy of sulpiride 200 and 400 mg and relate this to changes in task performance.
MATERIALS AND METHODS: Positron emission tomography scans were acquired in ten healthy volunteers with [11C]-raclopride. Striatal drug occupancy was calculated as the percentage change in binding potential between placebo and drug scans. All volunteers received placebo and sulpiride 400 mg, with four receiving 200 mg on a third session. Immediate post-scan neuropsychological assessment included working memory and learning tasks.
RESULTS: Striatal sulpiride occupancy was approximately 17% (200 mg) and approximately 28% (400 mg), with similar occupancy within the midbrain. Neuropsychological data analysis was restricted to the higher dose (n = 10). Accuracy on the spatial working memory and spatial learning tasks was impaired after the drug, and the former was inversely related to occupancy.
CONCLUSION: Doses of sulpiride typically used in human cognitive studies produced low levels of DA D2 receptor occupancy compared to that considered efficacious in the treatment of schizophrenia. The levels of occupancy were sufficient to replicate impairments on a spatial working memory task and impair spatial learning. The relationship between occupancy and working memory was suggestive of presynaptic effects, although the precise mechanism underlying the impairment will require studies of wider ranges of occupancy within and outside of the striatum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17912501     DOI: 10.1007/s00213-007-0947-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

2.  D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.

Authors:  L Farde; F A Wiesel; A L Nordström; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

4.  Tyrosine depletion attenuates dopamine function in healthy volunteers.

Authors:  C J Harmer; S F McTavish; L Clark; G M Goodwin; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

5.  Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

Authors:  M A Mehta; R Swainson; A D Ogilvie; J Sahakian; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

6.  Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

Authors:  Romina Mizrahi; Pablo Rusjan; Ofer Agid; Ariel Graff; David C Mamo; Robert B Zipursky; Shitij Kapur
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

7.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

Authors:  Michael J Frank; Randall C O'Reilly
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

8.  The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels.

Authors:  Mitul A Mehta; Deepa Gumaste; Andrew J Montgomery; Sarah F B McTavish; Paul M Grasby
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

9.  Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers.

Authors:  Mitul A Mehta; Facundo F Manes; Gianna Magnolfi; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

10.  Dopaminergic modulation of working memory for spatial but not object cues in normal humans.

Authors:  M Luciana; P F Collins
Journal:  J Cogn Neurosci       Date:  1997-05       Impact factor: 3.225

View more
  33 in total

1.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Francesco Napolitano; Gianluca Ursini; Paolo Taurisano; Raffaella Romano; Grazia Caforio; Leonardo Fazio; Barbara Gelao; Annabella Di Giorgio; Luisa Iacovelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Usiello; Alessandro Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning.

Authors:  Catherine J Wei; Philipp Singer; Joana Coelho; Detlev Boison; Joram Feldon; Benjamin K Yee; Jiang-Fan Chen
Journal:  Learn Mem       Date:  2011-06-21       Impact factor: 2.460

3.  Gastrodin ameliorates memory deficits in 3,3'-iminodipropionitrile-induced rats: possible involvement of dopaminergic system.

Authors:  Xiaona Wang; Shaofeng Yan; Aiqin Wang; Yanli Li; Feng Zhang
Journal:  Neurochem Res       Date:  2014-05-20       Impact factor: 3.996

4.  High long-term test-retest reliability for extrastriatal 11C-raclopride binding in healthy older adults.

Authors:  Nina Karalija; Lars Jonassson; Jarkko Johansson; Goran Papenberg; Alireza Salami; Micael Andersson; Katrine Riklund; Lars Nyberg; Carl-Johan Boraxbekk
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-10       Impact factor: 6.200

5.  Characterization of the guinea pig animal model and subsequent comparison of the behavioral effects of selective dopaminergic drugs and methamphetamine.

Authors:  Kiera-Nicole Lee; Samuel T Pellom; Ericka Oliver; Sanika Chirwa
Journal:  Synapse       Date:  2014-01-31       Impact factor: 2.562

6.  Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.

Authors:  Alessandro Bertolino; Leonardo Fazio; Grazia Caforio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Annabella Di Giorgio; Paolo Taurisano; Audrey Papp; Julia Pinsonneault; Danxin Wang; Marcello Nardini; Teresa Popolizio; Wolfgang Sadee
Journal:  Brain       Date:  2008-10-01       Impact factor: 13.501

7.  Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity.

Authors:  Lieke Hofmans; Danae Papadopetraki; Ruben van den Bosch; Jessica I Määttä; Monja I Froböse; Bram B Zandbelt; Andrew Westbrook; Robbert-Jan Verkes; Roshan Cools
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

8.  Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.

Authors:  Martin Darvas; Charles W Henschen; Richard D Palmiter
Journal:  Neurobiol Dis       Date:  2014-02-01       Impact factor: 5.996

9.  The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory.

Authors:  Chris M Dodds; Luke Clark; Anja Dove; Ralf Regenthal; Frank Baumann; Ed Bullmore; Trevor W Robbins; Ulrich Müller
Journal:  Psychopharmacology (Berl)       Date:  2009-08-12       Impact factor: 4.530

10.  Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study.

Authors:  Alexa M Morcom; Edward T Bullmore; Felicia A Huppert; Belinda Lennox; Asha Praseedom; Helen Linnington; Paul C Fletcher
Journal:  Cereb Cortex       Date:  2009-07-22       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.